N-[[(2,6-disubstituted)phenyl]-N'-diarylalkyl] ureas as antihyperlipidemic and antiatherosclerotic agents
申请人:WARNER-LAMBERT COMPANY
公开号:EP0335374A2
公开(公告)日:1989-10-04
Certain N-2,6-dialkyl- or N-2,6-dialkoxyphenyl-N′-diarylalkylurea compounds are potent inhibitors of the enzyme acyl CoA:cholesterol acyltransferase (ACAT), and are thus useful agents for the treatment of hypercholesterolemia or atherosclerosis with urea and thiourea compounds.
某些 N-2,6-二烷基或 N-2,6-二烷氧基苯基-N′-二芳基烷基脲化合物是酰基 CoA:胆固醇酰基转移酶(ACAT)的强效抑制剂,因此是用尿素和硫脲化合物治疗高胆固醇血症或动脉粥样硬化的有效药物。